UBS: Baxalta Is A Buy Even If Shire Buyout Doesn't Happen
UPDATE: Piper Jaffray Reiterates on LDR Holding Following Solid Top- and Bottom-Line Beat
UPDATE: Piper Jaffray Initiates Coverage on LDR Holding on Unique High-Growth, High-Value Portfolio
UPDATE: Piper Jaffray Upgrades Integra LifeSciences On FDA Inspection Results